REN and glomerular disorder: The use of a renin–angiotensin–aldosterone system blocker was perhaps the first treatment for which there was robust evidence of an ability to control the progression of kidney disease and proteinuria, which made it the standard treatment for many glomerulopathies, such as IgA nephropathy and diabetic nephropathy, and for chronic kidney disease itself (103, 104).